Literature DB >> 25160782

G-CSF displays restricted ability to promote Sca-1(+) cardiac stem cell proliferation in vitro.

Haijian Luo1, Giulio Bassi, Maddalena Tessari, Zhenyu Yang, Giuseppe Faggian.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) is a controversial chemical in cardiac cell therapy. Myocardial homing of mobilized bone marrow-derived cells is thought to play a critical role in observed G-CSF-induced cardiac repair; meanwhile, the activation of proliferative potential of cardiac stem cells (CSCs) residing in the heart is a significant challenge. The present study aims to investigate whether G-CSF receptor is expressed in adult resident Sca-1(+) CSCs and determine the effect of G-CSF treatment on the proliferation of CSCs. For cardiac cells isolation, 12-week-old male C57BL/6 mice were anesthetized in a chamber containing 2.5% isoflurane in oxygen, euthanized by CO2 inhalation and then sacrificed by cervical dislocation. Magnetic-activated cell sorting was employed to acquire highly purified Sca-1(+) CSCs. We found that G-CSF receptor was expressed in adult resident Sca-1(+) CSCs by immunofluorescence staining and Western blotting. Exposure of Sca-1(+) cells to G-CSF in the culture medium for 72 h induced time-dependent but self-limiting cell cycle acceleration with a restricted effect on the CSC proliferation. As a result, it has provided a new insight to focus on the association between cardiac G-CSF therapy and adult resident stem cell activation. It may suggest gaining a deeper insight into the mechanisms of the interaction between CSCs and G-CSF to develop a synergistic strategy based on resident stem cell and G-CSF therapy for heart disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25160782     DOI: 10.1007/s11010-014-2189-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

1.  Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction.

Authors:  Hidemasa Oh; Steven B Bradfute; Teresa D Gallardo; Teruya Nakamura; Vinciane Gaussin; Yuji Mishina; Jennifer Pocius; Lloyd H Michael; Richard R Behringer; Daniel J Garry; Mark L Entman; Michael D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

2.  Activation of diverse signaling pathways by ex-vivo delivery of multiple cytokines for myocardial repair.

Authors:  Mikhail Konoplyannikov; Khawaja Husnain Haider; Vien Khach Lai; Rafeeq P H Ahmed; Shujia Jiang; Muhammad Ashraf
Journal:  Stem Cells Dev       Date:  2012-10-05       Impact factor: 3.272

Review 3.  Cell therapy for the treatment of coronary heart disease: a critical appraisal.

Authors:  Kai C Wollert; Helmut Drexler
Journal:  Nat Rev Cardiol       Date:  2010-02-23       Impact factor: 32.419

4.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

5.  Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarction.

Authors:  Hyun-Jae Kang; Min-Kyung Kim; Hae-Young Lee; Kyung-Woo Park; Whal Lee; Young-Seok Cho; Bon-Kwon Koo; Dong-Ju Choi; Young-Bae Park; Hyo-Soo Kim
Journal:  Eur Heart J       Date:  2012-08-17       Impact factor: 29.983

6.  G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.

Authors:  Mutsuo Harada; Yingjie Qin; Hiroyuki Takano; Tohru Minamino; Yunzeng Zou; Haruhiro Toko; Masashi Ohtsuka; Katsuhisa Matsuura; Masanori Sano; Jun-ichiro Nishi; Koji Iwanaga; Hiroshi Akazawa; Takeshige Kunieda; Weidong Zhu; Hiroshi Hasegawa; Keita Kunisada; Toshio Nagai; Haruaki Nakaya; Keiko Yamauchi-Takihara; Issei Komuro
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

7.  G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs.

Authors:  Kenichiro Shimoji; Shinsuke Yuasa; Takeshi Onizuka; Fumiyuki Hattori; Tomofumi Tanaka; Mie Hara; Yohei Ohno; Hao Chen; Toru Egasgira; Tomohisa Seki; Kojiro Yae; Uichi Koshimizu; Satoshi Ogawa; Keiichi Fukuda
Journal:  Cell Stem Cell       Date:  2010-03-05       Impact factor: 24.633

Review 8.  G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?

Authors:  Winston Shim; Ashish Mehta; Sze Yun Lim; Guangqin Zhang; Chong Hee Lim; Terrance Chua; Philip Wong
Journal:  Cardiovasc Res       Date:  2010-09-17       Impact factor: 10.787

9.  Evidence for cardiomyocyte renewal in humans.

Authors:  Olaf Bergmann; Ratan D Bhardwaj; Samuel Bernard; Sofia Zdunek; Fanie Barnabé-Heider; Stuart Walsh; Joel Zupicich; Kanar Alkass; Bruce A Buchholz; Henrik Druid; Stefan Jovinge; Jonas Frisén
Journal:  Science       Date:  2009-04-03       Impact factor: 47.728

10.  Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction.

Authors:  Hans D Theiss; Lisa Gross; Markus Vallaster; Robert David; Stefan Brunner; Christoph Brenner; Petra Nathan; Gerald Assmann; Josef Mueller-Hoecker; Michael Vogeser; Gerhard Steinbeck; Wolfgang-M Franz
Journal:  Int J Cardiol       Date:  2013-05-11       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.